Cormedix Inc (CRMD)
5.335
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 12:56
Cormedix Accounts Payable (Quarterly): 4.280M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.280M |
September 30, 2023 | 2.386M |
June 30, 2023 | 2.900M |
March 31, 2023 | 1.447M |
December 31, 2022 | 2.202M |
September 30, 2022 | 1.767M |
June 30, 2022 | 2.496M |
March 31, 2022 | 1.74M |
December 31, 2021 | 2.210M |
September 30, 2021 | 1.107M |
June 30, 2021 | 0.9433M |
March 31, 2021 | 1.500M |
December 31, 2020 | 1.128M |
September 30, 2020 | 1.986M |
June 30, 2020 | 1.386M |
March 31, 2020 | 1.333M |
December 31, 2019 | 1.024M |
September 30, 2019 | 1.055M |
June 30, 2019 | 0.9061M |
March 31, 2019 | 1.462M |
December 31, 2018 | 2.589M |
September 30, 2018 | 7.882M |
June 30, 2018 | 7.309M |
March 31, 2018 | 3.660M |
December 31, 2017 | 1.808M |
Date | Value |
---|---|
September 30, 2017 | 1.408M |
June 30, 2017 | 1.766M |
March 31, 2017 | 1.726M |
December 31, 2016 | 1.645M |
September 30, 2016 | 1.758M |
June 30, 2016 | 1.108M |
March 31, 2016 | 1.581M |
December 31, 2015 | 1.709M |
September 30, 2015 | 1.425M |
June 30, 2015 | 1.142M |
March 31, 2015 | 1.429M |
December 31, 2014 | 0.8934M |
September 30, 2014 | 0.7403M |
June 30, 2014 | 0.8486M |
March 31, 2014 | 1.027M |
December 31, 2013 | 0.9398M |
September 30, 2013 | 0.9698M |
June 30, 2013 | 1.489M |
March 31, 2013 | 1.312M |
December 31, 2012 | 0.9286M |
September 30, 2012 | 0.9176M |
June 30, 2012 | 0.9938M |
March 31, 2012 | 1.425M |
December 31, 2011 | 0.9135M |
September 30, 2011 | 0.9901M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.9061M
Minimum
Jun 2019
4.280M
Maximum
Dec 2023
1.779M
Average
1.500M
Median
Mar 2021
Accounts Payable (Quarterly) Benchmarks
BioXcel Therapeutics Inc | 13.65M |
Assertio Holdings Inc | 13.44M |
Verastem Inc | 7.184M |
Ocular Therapeutix Inc | 4.389M |
PAVmed Inc | 1.786M |